Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnteq Tech Regulatory News (NTQ)

  • This share is currently suspended. It was suspended at a price of 0.4999
  • There is currently no data for NTQ

Trading Statement

8 Apr 2020 07:00

RNS Number : 1290J
Enteq Upstream PLC
08 April 2020
 

8 April 2020

Enteq Upstream plc

("Enteq" or the "Company")

 

Year-end Trading and COVID 19 Update

 

Enteq, the oilfield services technology and equipment supplier, today announces an update for the financial year ended 31 March 2020.

 

The combined and inter-related impact of both the COVID-19 virus spreading and the recent drastic reduction in the oil price has had a significant impact on Enteq's current and future trading environment.

 

The health and safety of staff, their families and the broader community is our highest priority. Following advisory guidelines, our facilities in Houston have been re-organized to ensure safe working practices, together with enabling staff to work from home, where practical. All UK employees are now operating from their homes.

Enteq trading results for the year ended 31 March 2020 are anticipated to remain broadly in-line with the Board's earlier full-year expectations, with revenues in the region of $11m and Underlying Adjusted EBITDA* of around $3m. The cash balance as of 31 March 2020 was $10.2m ($11.9m as at 31 March 2019; $10.7m as at 30 September 2019) reflecting planned investments made during the year in the rental fleet, engineering projects and product development.

 

Due to the recent reduction in demand from the North American drilling market, combined with the future market uncertainties, Enteq intends to include a significant non-cash write down in the carrying value of both the intangible assets (capitalised research and development projects) and inventory holdings in the final reported accounts for this period. The total balance sheet (non-cash) reduction in relation to these write downs is expected to be approximately $6.9m.

 

Shortly after the dramatic fall in global oil price in mid-March 2020 many operators in the North American shale oil and gas sector announced measures to significantly reduce both capital expenditure and operating costs. Enteq responded by rapidly reducing its overhead cost base. The actions taken to date include:

· reducing the number of our US workforce by approximately 60%, with group wide salary reductions implemented from 1 April 2020;

· releasing all contract staff and curtailing all discretionary spend.

 

In addition, in order to further conserve cash, all Board members have agreed to take a significant proportion of their remuneration in new Enteq shares. Enteq is also in the process of applying for governmental assistance in the USA, where appropriate.

 

Enteq's secure balance sheet, combined with an adjusted cost base, will allow for continued investment in selected engineering development projects. Strong technical partnerships will also be maintained.

 

In the current circumstances it is not possible to give guidance as to the expected level of future trading in the medium term. Enteq's International markets, especially China, Russia and in Saudi Arabia (where a new partnership agreement has now been concluded), are expected to be more resilient than North America and Enteq continues to pursue opportunities in these areas.

 

The Company currently expects to report its full year results for the year ended 31 March 2020 on 17 June 2020.

 

 

For further information, please contact:

 

Enteq Upstream plc +44 (0)149 461 8739

Martin Perry, Chief Executive Officer

David Steel, Finance Director

 

Investec Bank plc (NOMAD and Broker) +44 (0)207 597 5970

Chris Treneman, Patrick Robb, David Anderson

 

 

 

* Underlying EBITDA is defined as operating profit before depreciation, amortisation, long term incentive charges and exceptional items. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDDLFBBZLXBBK
Date   Source Headline
16th May 201712:01 pmRNSHolding(s) in Company
2nd May 20173:36 pmRNSTechnology Development Grant
12th Apr 20177:00 amRNSTrading Statement
14th Mar 201711:03 amRNSDirector/PDMR Shareholding
16th Dec 201611:45 amRNSIssue of Shares
18th Nov 20167:00 amRNSHalf-year Report
26th Oct 20162:36 pmRNSHolding(s) in Company
24th Oct 20161:11 pmRNSHolding(s) in Company
16th Sep 201610:15 amRNSIssues of Shares
13th Sep 20164:21 pmRNSResult of AGM
13th Sep 201611:06 amRNSAGM Statement
4th Jul 201610:42 amRNSAdditional Listing
23rd Jun 20164:04 pmRNSAwards under the Performance Share Plan ("PSP")
21st Jun 201610:15 amRNSAdditional Listing
15th Jun 20167:00 amRNSFinal Results
25th Apr 201610:40 amRNSHolding(s) in Company
22nd Apr 20164:46 pmRNSHolding(s) in Company
22nd Apr 20164:44 pmRNSHolding(s) in Company
20th Apr 20167:00 amRNSYear-end update and proposed Board changes
24th Nov 201510:34 amRNSIssue of Shares
19th Nov 20153:57 pmRNSHolding(s) in Company
18th Nov 201510:48 amRNSHolding(s) in Company
13th Nov 20157:00 amRNSInterim results for six months ended 30 Sept 2015
15th Sep 20151:00 pmRNSResult of AGM
15th Sep 20157:00 amRNSAGM Statement
7th Jul 20153:20 pmRNSHolding(s) in Company
29th Jun 20156:06 pmRNSDirector/PDMR Shareholding
25th Jun 20156:21 pmRNSAdditional Listing
19th Jun 201511:01 amRNSAdditional Listing
16th Jun 20157:00 amRNSFinal Results
28th May 20154:35 pmRNSPrice Monitoring Extension
29th Apr 20157:00 amRNSYear End Update
6th Feb 201510:04 amRNSHolding(s) in Company
19th Jan 20154:16 pmRNSDirector/PDMR Shareholding
15th Jan 20157:00 amRNSTrading Statement
2nd Dec 20144:45 pmRNSHolding(s) in Company
21st Nov 20149:39 amRNSDirector/PDMR Shareholding
18th Nov 20147:00 amRNSHalf Yearly Report
6th Nov 20145:37 pmRNSHolding(s) in Company
14th Oct 20147:00 amRNSTrading Statement
6th Oct 201410:44 amRNSHolding(s) in Company
6th Oct 20149:59 amRNSHolding(s) in Company
18th Sep 20147:00 amRNSDirector/PDMR Shareholding
12th Sep 20144:17 pmRNSDirector/PDMR Shareholding
11th Sep 20141:00 pmRNSAGM Statement
17th Jul 201410:51 amRNSHolding(s) in Company
11th Jul 20143:07 pmRNSDirector/PDMR Shareholding
19th Jun 20143:07 pmRNSHolding(s) in Company
18th Jun 20147:00 amRNSDirector/PDMR Shareholding
16th Jun 20147:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.